Table 2 Distribution of the outcomes among all singleton pregnancies resulting in livebirth in Sweden, by proton pump inhibitor (PPI) exposure
| Â | Total | PPI users | PPI non-users | |||
|---|---|---|---|---|---|---|
| Â | N | % | N | % | N | % |
Total | 1,089,515 | 100.00% | 14,787 | 1.40% | 1,074,728 | 98.60% |
Pre-eclampsia | ||||||
Yes | 35,791 | 3.30% | 723 | 4.90% | 35,068 | 3.30% |
No | 1,053,724 | 96.70% | 14,064 | 95.10% | 1,039,660 | 96.70% |
Gestational diabetes | ||||||
Yes | 15,958 | 1.50% | 475 | 3.20% | 15,483 | 1.40% |
No | 1,073,557 | 98.50% | 14,312 | 96.80% | 1,059,245 | 98.60% |
Preterm birth | ||||||
Yes | 50,765 | 4.70% | 966 | 6.50% | 49,799 | 4.60% |
No | 1,038,750 | 95.30% | 13,821 | 93.50% | 1,024,929 | 95.40% |
Low Apgar score | ||||||
Yes | 12,834 | 1.20% | 239 | 1.60% | 12,595 | 1.20% |
No | 1,076,681 | 98.80% | 14,548 | 98.40% | 1,062,133 | 98.80% |
Birthweight for gestational age | ||||||
Small | 24,690 | 2.30% | 472 | 3.20% | 24,218 | 2.30% |
Average | 1,027,099 | 94.20% | 13,737 | 92.90% | 1,013,362 | 94.30% |
Large | 37,726 | 3.50% | 578 | 3.90% | 37,148 | 3.50% |